HØRSHOLM, Denmark--(BUSINESS WIRE)--In accordance with Section 6 of the Danish Statutory Order on Issuers’ Disclosure Obligations, LifeCycle Pharma A/S (CSE:LCP) is required to publish the total number of voting rights and the size of the share capital in LifeCycle Pharma A/S at the end of each calendar month where there has been a change.
